Microbot Medical (NASDAQ:MBOT) Shares Pass Above 200-Day Moving Average – What’s Next?

Microbot Medical Inc. (NASDAQ:MBOT)’s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.99 and traded as high as $1.02. Microbot Medical shares last traded at $1.01, with a volume of 116,758 shares changing hands.

Microbot Medical Trading Up 0.1 %

The firm has a market capitalization of $16.48 million, a price-to-earnings ratio of -1.22 and a beta of 1.62. The business’s fifty day moving average price is $0.97 and its 200 day moving average price is $0.99.

Institutional Investors Weigh In On Microbot Medical

A hedge fund recently bought a new stake in Microbot Medical stock. Thoroughbred Financial Services LLC bought a new stake in Microbot Medical Inc. (NASDAQ:MBOT) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 52,250 shares of the biotechnology company’s stock, valued at approximately $53,000. Thoroughbred Financial Services LLC owned about 0.33% of Microbot Medical at the end of the most recent quarter. Institutional investors own 16.30% of the company’s stock.

About Microbot Medical

Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.